Heart Failure Clinical Trials in Ho Chi Minh City
6 recruitingHo Chi Minh City, Vietnam
Showing 1–6 of 6 trials
Recruiting
Phase 3
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Heart Failure
Boehringer Ingelheim4,200 enrolled641 locationsNCT06935370
Recruiting
Phase 3
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
Heart Failure and Impaired Kidney Function
AstraZeneca4,800 enrolled842 locationsNCT06307652
Recruiting
Phase 3
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Boehringer Ingelheim6,000 enrolled652 locationsNCT06424288
Recruiting
Phase 3
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Heart Failure
AstraZeneca11,300 enrolled917 locationsNCT06677060
Recruiting
Not Applicable
The Effect of Resistance Training on Sarcopenia in Older Heart Failure Patients
Chronic Heart FailureSarcopenia in Elderly
Kieu Nguyen Dang Phuong146 enrolled2 locationsNCT06785168
Recruiting
Demographic, Clinical, Biological, Treatment Characteristics and Cardiovascular Events of Patients With Heart Failure in Vietnam: a Multicenter Prospective Observational Study
Heart FailureHeart Failure With Reduced Ejection FractionHeart Failure With Mid Range Ejection Fraction
University Medical Center Ho Chi Minh City (UMC)2,500 enrolled1 locationNCT06516562